Skip to main content
Equibles
DQWS logo

DQWS · DSwiss Inc · Metrics

Track DQWS — free

Use DQWS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DQWS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.08 At close · Sep 17
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As reflected in the accompanying financial statements, for the period ended June 30, 2026, the Company’s current liabilities exceeded its current assets by $91,418, suffered an accumulated deficit of $1,463,001 and negative operating cash flow of $5,298. This factor raises substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$17.38M
Shares
206.90M
Volume · Sep 17 17.4K Avg daily vol (7 sessions) 9390

DQWS metrics

63 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.08
Market cap
$17.38M

Price action

20 metrics
Price change (1W)
+162.5%
Price change (30D)
—
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
-16.0%
Trailing year
Price change (5Y)
—
52-week high
$0.09
52-week low
$0.03
Change from 52-week high
-1.2%
Change from 52-week low
+236.0%
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
60.4
Price vs SMA 50
+89.5%
Price vs SMA 200
+4.7%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Consumer Defensive
Industry
Household & Personal Products
Shares outstanding
206.90M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
9.1×
reciprocal yield 11.0%
EV / EBITDA
220.1×
reciprocal yield 0.5%
EV / EBIT
—
P / sales
9.2×
reciprocal yield 10.9%
P / book
—
FCF yield
-1.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-1.4%

Historical valuation

8 metrics
P / E historical average (3Y)
270.9×
reciprocal yield 0.4%
P / E historical average (5Y)
270.9×
reciprocal yield 0.4%
EV / revenue historical average (3Y)
6.2×
reciprocal yield 16.1%
EV / revenue historical average (5Y)
7.0×
reciprocal yield 14.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
25.5%
Operating margin
0.0%
Trailing 12 months
Net margin
-13.0%
Gross profit (TTM)
$481,453
Operating profit (TTM)
−$1,056
Net income (TTM)
−$245,935
Trailing 12 months
Diluted EPS (TTM)
$0.00
FCF margin
-15.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.01
Gross profit per diluted share (TTM)
$0.00
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.00
Operating cash flow per diluted share (TTM)
$0.00
Free cash flow per diluted share (TTM)
$0.00
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.00

Growth

11 metrics
Revenue growth YoY
-49.9%
Year over year
Net income growth YoY
-107.8%
Revenue (TTM)
$1.89M
Trailing 12 months
EPS growth YoY
-106.7%
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
+16.5%
Revenue CAGR (5Y)
+16.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-38.6%
Debt / equity
—
Current ratio
0.8
EBITDA (TTM)
$78,274
Free cash flow (TTM)
−$287,173
Quick ratio
0.8
Interest coverage
—
Net debt / EBITDA
-1.9
Return on invested capital
—
Trailing 12 months
Net cash
$149,725
Latest balance sheet
Cash & equivalents
$257,989
Total assets
$637,223
Total debt
$108,264

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$248,186
Capital expenditures (TTM)
$38,987
R&D (TTM)
—
SG&A (TTM)
$685,751
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
7 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1652561 CUSIP 26251W100 Visit website Investor relations